Expert opinion

On the afternoon of July 17, 2025, at Dong Do General Hospital, representatives from GENTIS (Genetic Analysis Services JSC) had a working session and professional exchange with the hospital's team of obstetricians and reproductive specialists. The meeting focused on introducing and providing in-depth updates on the Genratest – an advanced tool that improves treatment outcomes in assisted reproductive technology (ART), especially for patients who have experienced repeated implantation failure (RIF).

The diagnosis and treatment of genetic diseases have become one of the most rapidly advancing fields in medicine, bringing new hope to millions of patients around the world. With the development of technology, from early diagnostic techniques to optimized treatment methods, the detection and management of genetic disorders have become more accurate and effective than ever. These groundbreaking solutions not only improve patients' quality of life but also lay a solid foundation for the future.

From a startup in France, Eurofins has grown into one of the world’s leading scientific groups, particularly in the field of biological testing, including medical testing, with over 900 laboratories worldwide. The integration of GENTIS into the Eurofins network marks a strategic turning point, ushering in a new era for genetic testing in Vietnam and Southeast Asia.

The ART ADVANCED 12 conference is a significant scientific event in the field of reproductive support organized by the Hanoi Reproductive Support Association. With the theme “New Perspectives on Reproductive Science: From Clinical Data to Personalized Treatment,” the conference will provide in-depth updates and important discussions about advances in reproductive support. This is an opportunity for experts to meet, share experiences, and move towards personalized treatment to improve clinical practice outcomes.

In modern medicine, particularly in the diagnosis and screening of genetic diseases, the collaboration between clinical doctors, geneticists, and genetic laboratories plays an extremely important role. This is a closed-loop process that ensures patients receive accurate results, supporting the best treatment and prognosis possible.

On March 8, 2025, Dr. Pham Dinh Minh (Director of R&D GENTIS - Director of GENTIS Genetic Counseling Center) gave a report at the 7th Tzu Chi - Academia Sinica Biomedical Conference at Tzu Chi University, Hualien, Taiwan. The report was on the topic: "Development and application of AI/Bioinformatics in genetic and genomic testing in Vietnam".

During her visit and work in Vietnam, Assoc. Prof. Dr. Francesca Spinella (Senior Medical Information Specialist at Eurofins Genoma Group, Former President of ESHRE PGT Consortium) expressed her admiration for the remarkable advancements made by genetic testing laboratories in the diagnosis and treatment within the field of reproductive medicine. In particular, she praised GENTIS for both its professional expertise and state-of-the-art facilities. She mentioned that the collaboration between GENTIS and GENOMA will enhance multi-level development among global healthcare organizations, particularly in the area of genetic testing.